IP Library Granted Patent US 6,943,211
Granted Patent B1
US 6,943,211 · App. 09/644,121 · Granted Sep 13, 2005

Polymer compounds

Assignee: Life Medical Sciences, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,943,211
App. No.
09/644,121
Granted
Sep 13, 2005
Kind
B1
Abstract

Provided is a composition comprising a pre-formed, hydrolytically susceptible non-addition polyanionic polymer comprising polymer strands formed from at least one ethylenically unsaturated monomer and linking the polymer strands by at least one linking moiety comprising a hydrolytically susceptible bond, wherein at least one of which monomers has: i) one or more functional groups that can be titrated with base to form negatively charged functional groups; or ii) one or more precursor groups that are precursors of the functional groups that can be titrated with base; which precursor groups are converted to the functional groups.

Claims (15)

1. A composition comprising a pre-formed, hydrolytically susceptible non-addition polyanionic polymer comprising polymer strands formed from at least one ethylenically unsaturated monomer, wherein the polymer strands are linked by at least one linking moiety comprising a hydrolytically susceptible bond formed with a multidentate compound comprising two or more ethylenically unsaturated moieties, each such moiety being linked to the multidentate compound through a hydrolytically susceptible bond, wherein at least one of which monomers has:

i) one or more functional groups that can be titrated with base to form negatively charged functional groups, or

ii). one or more precursor groups that are precursors of the functional groups that can be titrated with base; which precursor groups are converted to the functional groups;

wherein at least one of the ethylenically unsaturated monomers is according to the formula:

(R 3 )(R 2 )C═C(R 1 )—X—Y

wherein:

Y is —C(O)OR 4 ; —O—S(O 2 )OR 4 ; —S(O 2 )OR 4 ; or —S(O)OR 4 ; wherein R 4 is hydrogen or a cleavage permitting group;

X is a direct bond; a straight or branched alkylene group having one to six carbon atoms, one or more of which can be replaced by O, S, or N heteroatoms, provided that there is no heteroatom in a position α or β to Y; phenylene; a five or six membered heteroarylene having up to three heteroatoms independently selected from O, S, and N, provided that neither Y or (R 3 )(R 2 )C═C(R 1 )— is bonded to a heteroatom; and

R 1 , R 2 and R 3 are independently selected from, hydrogen, C 1 -C 6 alkyl, carboxy, halogen, cyano, isocyanato, C 1 -C 6 hydroxyalkyl, alkoxyalkyl having 2 to 12 carbon atoms, C 1 -C 6 haloalkyl, C 1 -C 6 cyanoalkyl, C 3 -C 6 cycloalcyl, C 1 -C 6 carboxyalkyl, aryl, hydroxyaryl, haloaryl, cyanoaryl, C 1 -C 6 alkoxyaryl, carboxyaryl, nitroaryl, or a group —X—Y; wherein C 1 -C 6 alkyl or C 1 -C 6 alkoxy groups are either linear or branched and up to Q-2 carbon atoms of any C 3 -C 6 cycloalkyl group, wherein Q is the total number of ring carbon atoms in the cycloalkyl group, are independently replaced with O, S, or N heteroatoms; with the proviso that neither doubly-bonded carbon atom is directly bonded to O or S; and wherein aryl is phenyl or a 5 or 6 membered heteroaryl having up to three heteroatoms selected from the group consisting of O, S, and N.

2. The composition of claim 1 , wherein the linking moiety is formed by copolymerization of an ethylenically unsaturated linking agent, and the mole fraction of ethylenic double bonds in the combination from which the polyanionic polymer is made that is contributed by the ethylenically unsaturated linking agent is 0.02 or less.

3. The composition of claim 1 , comprising a microgel formed of the polyanionic polymer.

4. The composition of claim 3 , wherein the microgel has a ratio of the macroviscosity of the microgel to the microviscosity of the microgel is 10,000 or less.

5. The composition of claim 1 , wherein the polyanionic polymer is functionalized to provide one or more pendant functional groups selected from hydroxy, acyl halide, chloroformate, and mercapto; and wherein

the linking moiety provides crosslinking and is a reaction product of the pendant groups between polymer segments or between the pendant groups and complementing functions groups of a linking group.

6. The composition of claim 5 , wherein the linking agent is the diacrylate of an α,ω-diol or the diacrylate of a chain extended α,ω-diol.

Assignments (3)
CHANGE OF NAME Recorded Jun 26, 2013
From: SYNTHEMED, INC
To: PATHFINDER CELL THERAPY, INC.
Reel/Frame 030694/0983 →
SECURITY AGREEMENT Recorded Sep 16, 2010
From: SYNTHEMED, INC.
To: PATHFINDER, LLC
Reel/Frame 025000/0207 →
CHANGE OF NAME Recorded Apr 29, 2009
From: LIFE MEDICAL SCIENCES, INC.
To: SYNTHEMED, INC.
Reel/Frame 022610/0395 →
Continuity (1)
Continuation In Part 0925648400 · Feb 23, 1999